What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Heart failure
- Gene
His primary scientific interests are in Internal medicine, Heart failure, Cardiology, Ejection fraction and Heart failure with preserved ejection fraction.
His Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Endoplasmic reticulum.
In Heart failure, Burkert Pieske works on issues like Intensive care medicine, which are connected to Electrocardiography and Cardiotonic Agents.
The various areas that he examines in his Cardiology study include Placebo and Transplantation.
His Ejection fraction research integrates issues from Tolerability, Soluble Guanylate Cyclase Stimulator and Clinical endpoint.
His study looks at the relationship between Heart failure with preserved ejection fraction and fields such as Spironolactone, as well as how they intersect with chemical problems.
His most cited work include:
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. (9345 citations)
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (6276 citations)
- ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. (5331 citations)
What are the main themes of his work throughout his whole career to date?
Burkert Pieske mainly investigates Internal medicine, Cardiology, Heart failure, Endocrinology and Ejection fraction.
When carried out as part of a general Internal medicine research project, his work on Heart failure with preserved ejection fraction, Diastole, Atrial fibrillation and Blood pressure is frequently linked to work in In patient, therefore connecting diverse disciplines of study.
His research on Cardiology frequently connects to adjacent areas such as Magnetic resonance imaging.
His biological study spans a wide range of topics, including Placebo, Disease, Confidence interval and Intensive care medicine.
His research in Endocrinology intersects with topics in Receptor and Calcium.
His Ejection fraction study frequently draws connections to other fields, such as Cardiac magnetic resonance imaging.
He most often published in these fields:
- Internal medicine (80.45%)
- Cardiology (53.76%)
- Heart failure (40.69%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (80.45%)
- Cardiology (53.76%)
- Heart failure (40.69%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Cardiology, Heart failure, Ejection fraction and Heart failure with preserved ejection fraction.
His Internal medicine study frequently draws parallels with other fields, such as Endocrinology.
Burkert Pieske has included themes like Magnetic resonance imaging and Cardiac magnetic resonance imaging in his Cardiology study.
He has researched Heart failure in several fields, including Muscle hypertrophy, Asymptomatic and Proportional hazards model.
His study explores the link between Ejection fraction and topics such as Placebo that cross with problems in Randomization and Interquartile range.
His Heart failure with preserved ejection fraction study also includes
- Sacubitril, Valsartan, which have a strong connection to Blood lipids,
- Randomized controlled trial together with Clinical trial.
Between 2019 and 2021, his most popular works were:
- Vericiguat in Patients With Heart Failure and Reduced Ejection Fraction (138 citations)
- Periodontitis and cardiovascular diseases: Consensus report (97 citations)
- Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF. (72 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Heart failure
His scientific interests lie mostly in Internal medicine, Heart failure, Cardiology, Ejection fraction and Heart failure with preserved ejection fraction.
His Heart failure research includes elements of Stroke, Autoantibody, Disease and Aptamer.
His Stroke research is multidisciplinary, incorporating elements of Periodontitis, Severe periodontitis, Intensive care medicine and Epidemiology.
His work on Cardiology is being expanded to include thematically relevant topics such as Framingham Risk Score.
Within one scientific family, Burkert Pieske focuses on topics pertaining to Placebo under Ejection fraction, and may sometimes address concerns connected to Decompensation, Multicenter trial, Population study, Adverse effect and Cardiac magnetic resonance imaging.
The Heart failure with preserved ejection fraction study combines topics in areas such as Valsartan and Interval training.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
